Advanced methodologies have revolutionized our understanding of biological processes in health and in illnesses, offering new opportunities for early diagnosis, to develop personalized therapies, and to discover prognostic biomarkers
The group’s objective is to test technology and expertise to evaluate the structure and activity of proteins and their interactions with small molecules (pharmaceuticals and drugs) or macromolecules (DNA, RNA, and carbohydrates), making it possible to identify modifications in metabolic profiles and potential alterations in metabolic pathways
The group specializes in the characterization of biomolecules, from the synthesis of oligonucleotides and peptides to the crystallization of proteins. Its expertise lies in the biophysical and structural characterization of proteins, macromolecules, nanoparticles and polymers in solution